Skip to main content

Larimar Therapeutics, Inc.

LRMR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
SEC CIK
0001374690

In the last 90 days, Larimar Therapeutics, Inc. insiders filed 1 open-market purchase and 0 sales; 163 institutions reported holding it in 13F filings for Q2 2026, worth $291.4M in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Larimar Therapeutics, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024All holders in Q3 2024

13F holders of LRMR: Q3 2024 compared with Q4 2024
MeasureQ3 2024Of which not filed for Q4 2024Q4 2024Change
Holders1232116−5
Shares64.3M235.0K63.4M−659.3K (−1.0%)
Value$421.3M$1.54M$245.5M−$174.3M (−41.5%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (22)

Institutions that held Larimar Therapeutics, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to LRMR in Q4 2024
InstitutionSharesValue% of portfolio
Balyasny Asset Management LLC79,496$307.6K0.00%
Alps Advisors Inc51,590$199.7K0.00%
Monimus Capital Management, LP47,100$182.3K0.17%
Jain Global LLC31,787$123.0K0.00%
Walleye Trading LLC25,000$96.8K0.00%
Axq Capital, LP23,578$91.2K0.04%
Aquatic Capital Management LLC18,160$70.3K0.00%
Velan Capital Investment Management LP18,000$69.7K0.06%
ProShare Advisors LLC14,870$57.5K0.00%
Graham Capital Management, L.P.14,078$54.5K0.00%
China Universal Asset Management Co., Ltd.13,529$52.4K0.00%
Algert Global LLC12,190$47.2K0.00%
Engineers Gate Manager LP11,270$43.6K0.00%
Police & Firemen's Retirement System of New Jersey9,082$35.1K0.00%
BNP Paribas Arbitrage, SA6,465$25.0K0.00%
Diadema Partners LP3,800$14.7K0.02%
Mirae Asset Global Investments Co., Ltd.2,126$8.42K0.00%
GF Fund Management Co. Ltd.1,340$5.19K0.00%
R Squared Ltd720$2.79K0.00%
Larson Financial Group LLC120$4640.00%
SBI Securities Co., Ltd.118$4570.00%
IFP Advisors, Inc4$150.00%

Sold out (27)

Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Not filed for Q4 2024 yet (2)

Institutions that held Larimar Therapeutics, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding LRMR in Q3 2024 that haven't filed for Q4 2024
InstitutionShares, Q3 2024Value, Q3 2024
Ghost Tree Capital, LLC200,000$1.31M
PEAK6 Investments LLC35,000$229.3K